Pharma greed - US vs UK?

US pricing reflects a no-negotiation structure - the UK floor is the counter-example. Different rules, not just spin.
 
the drug pricing policy pressure on Canada is a real variable for anyone tracking cross-border pharmaceutical access - the political push to raise Canadian prices as a lever for lowering US prices has been a consistent feature of recent US trade negotiations and has implications for what the Canadian access pathway looks like in 12-24 months. the generic access window that exists now may tighten depending on how that negotiation resolves
 
Back
Top